GREAT WEST LIFE ASSURANCE CO /CAN/ - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$13,000
-23.5%
2,6230.0%0.00%
Q2 2021$17,000
-15.0%
2,6230.0%0.00%
Q1 2021$20,000
+17.6%
2,6230.0%0.00%
Q4 2020$17,0000.0%2,6230.0%0.00%
Q3 2020$17,000
-22.7%
2,6230.0%0.00%
Q2 2020$22,000
+10.0%
2,6230.0%0.00%
Q1 2020$20,000
-9.1%
2,6230.0%0.00%
Q4 2019$22,000
-60.0%
2,623
-46.9%
0.00%
Q2 2019$55,000
+3.8%
4,9430.0%0.00%
Q1 2019$53,000
-26.4%
4,9430.0%0.00%
Q4 2018$72,000
-20.9%
4,9430.0%0.00%
Q3 2018$91,000
-19.5%
4,9430.0%0.00%
Q2 2018$113,000
+121.6%
4,943
+174.6%
0.00%
Q1 2018$51,000
+34.2%
1,8000.0%0.00%
Q4 2017$38,000
+18.8%
1,8000.0%0.00%
Q3 2017$32,000
+14.3%
1,8000.0%0.00%
Q2 2017$28,000
-9.7%
1,8000.0%0.00%
Q1 2017$31,000
+55.0%
1,8000.0%0.00%
Q4 2016$20,000
-64.3%
1,800
-50.0%
0.00%
Q3 2016$56,000
+211.1%
3,600
+100.0%
0.00%
Q2 2016$18,0001,8000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders